WCN 2025
Advertisement
Can SZC help with RAASi maximization without resultant hyperkalemia in patients with HFrEF and CKD?
Interim APPLAUSE-IgAN data showed that iptacopan was superior to placebo at reducing proteinuria at nine months.
Current eligibility criteria for simultaneous heart and kidney transplantation may be subject to eGFRcr errors.
How accurately and efficiently does artificial intelligence perform clinical prescreening compared with nephrologists?
The WRAPSODY stent may help restore circuit patency when stenosis or occlusion occurs within the AVG or AVF for hemodialysis.
A MAMS platform trial will examine use of antiproteinuric and immunomodulatory therapies in glomerular diseases.
Zigakibart for treatment of IgA nephropathy (IgAN) was well tolerated, reduced proteinuria, and stabilized eGFR at 76 weeks.
A clinical trial examined the relationship between steroid exposure and bone mineral density changes in children.
An analysis sought to determine the economic costs of treating SARS-CoV-2 infection among kidney transplant recipients.
The International Society of Nephrology (ISN) has announced the 2025 recipients of the ISN Awards and ISN Pioneer Awards.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.